L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study ; volume:16 ; number:1 ; day:4 ; month:8 ; year:2016 ; pages:1-8 ; date:12.2016
BMC cancer ; 16, Heft 1 (4.8.2016), 1-8, 12.2016
- Urheber
-
Smogeli, Elisabeth
- Beteiligte Personen und Organisationen
-
Davidson, Ben
Cvancarova, Milada
Holth, Arild
Katz, Betina
Risberg, Bjørn
Kristensen, Gunnar
Lindemann, Kristina
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2631-4
- URN
-
urn:nbn:de:1111-20160901700
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smogeli, Elisabeth
- Davidson, Ben
- Cvancarova, Milada
- Holth, Arild
- Katz, Betina
- Risberg, Bjørn
- Kristensen, Gunnar
- Lindemann, Kristina
- SpringerLink (Online service)
Ähnliche Objekte (12)
CyclinD1, a prominent prognostic marker for endometrial diseases
Evaluation of Vav3.1 as prognostic marker in endometrial cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Interpretable prognostic modeling of endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer
Prognostic significance of miR-194 in endometrial cancer
CyclinD1, a prominent prognostic marker for endometrial diseases
Evaluation of Vav3.1 as prognostic marker in endometrial cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Interpretable prognostic modeling of endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer
Prognostic significance of miR-194 in endometrial cancer
CyclinD1, a prominent prognostic marker for endometrial diseases
Evaluation of Vav3.1 as prognostic marker in endometrial cancer
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Interpretable prognostic modeling of endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer